$ALT
Altimmune Inc Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-K Financial Statement

#000114420417014528 Filed on March 14, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q3
Revenue	$299.6K	$1.080M	$901.0K
YoY Change	-70.34%	-14.96%	-22.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.030M	$1.800M	$3.290M
YoY Change	70.59%	83.67%	167.48%
% of Gross Profit
Research & Development	$2.786M	$2.380M	$2.401M
YoY Change	170.73%	103.42%	113.25%
% of Gross Profit
Depreciation & Amortization	$12.97K	$20.00K	$32.24K
YoY Change	-67.59%	-33.33%	-7.91%
% of Gross Profit
Operating Expenses	$4.817M	$4.180M	$5.691M
YoY Change	368.03%	91.74%	102.2%
Operating Profit	-$4.517M	-$5.512M	-$4.790M
YoY Change	260.09%	486.13%	188.78%
Interest Expense	$60.60K	-$10.00K	$9.408K
YoY Change	5671.71%	-96.43%	-4.85%
% of Operating Profit
Other Income/Expense, Net	-$61.71K	$40.00K	-$5.537K
YoY Change			-101.59%
Pretax Income	-$4.579M	-$3.060M	-$4.795M
YoY Change	278.41%	150.82%	266.22%
Income Tax	-$1.001M	$0.00	$15.44K
% Of Pretax Income
Net Earnings	-$4.579M	$77.80M	-$4.795M
YoY Change	273.2%	-6382.43%	261.95%
Net Earnings / Revenue	-1528.45%	7203.85%	-532.17%
Basic Earnings Per Share		$1.16	$1.68
Diluted Earnings Per Share	-$19.91M	$1.15	$1.67
COMMON SHARES
Basic Shares Outstanding	68.82M shares	66.73M shares	65.00M shares
Diluted Shares Outstanding			65.81M shares

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.80M	$2.900M	$135.9M
YoY Change	11.27%	-81.41%	681.03%
Cash & Equivalents	$15.78M	$2.876M	$69.11M
Short-Term Investments	$0.00		$66.80M
Other Short-Term Assets	$500.0K	$400.0K	$500.0K
YoY Change	0.0%	100.0%	150.0%
Inventory
Prepaid Expenses
Receivables	$1.000M	$400.0K	$1.600M
Other Receivables	$1.000M	$800.0K	$0.00
Total Short-Term Assets	$18.29M	$4.487M	$138.0M
YoY Change	13.62%	-73.95%	656.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$87.94K	$177.9K	$153.8K
YoY Change	-56.03%	-23.89%	-38.04%
Goodwill	$2.348M	$18.76M	$2.348M
YoY Change		-16.61%	0.0%
Intangibles		$14.95M
YoY Change
Long-Term Investments
YoY Change
Other Assets		$22.25K	$0.00
YoY Change		-58.32%	-100.0%
Total Long-Term Assets	$2.436M	$33.91M	$2.502M
YoY Change	-6.29%	1186.77%	-5.58%
TOTAL ASSETS
Total Short-Term Assets	$18.29M	$4.487M	$138.0M
Total Long-Term Assets	$2.436M	$33.91M	$2.502M
Total Assets	$20.73M	$38.40M	$140.5M
YoY Change	10.85%	93.33%	572.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$839.5K	$2.005M	$614.5K
YoY Change	319.73%	284.79%	100.72%
Accrued Expenses	$1.400M	$2.973M	$2.000M
YoY Change	-30.0%	85.8%	-4.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$500.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.235M	$5.471M	$3.728M
YoY Change	-14.05%	151.01%	56.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$442.6K	$442.6K	$427.1K
YoY Change	-11.48%	2.12%	-0.91%
Total Long-Term Liabilities	$442.6K	$442.6K	$427.1K
YoY Change	-11.48%	2.12%	-0.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.235M	$5.471M	$3.728M
Total Long-Term Liabilities	$442.6K	$442.6K	$427.1K
Total Liabilities	$2.677M	$6.193M	$4.156M
YoY Change	-13.64%	92.73%	28.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.07M	-$31.26M	-$107.7M
YoY Change	-85.74%	-86.03%	-51.61%
Common Stock	$6.882K	$692.00	$6.642K
YoY Change		-89.25%	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.10M	$32.21M	$136.4M
YoY Change
Total Liabilities & Shareholders Equity	$20.73M	$38.40M	$140.5M
YoY Change	10.64%	93.33%	572.57%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	-$4.579M	$77.80M	-$4.795M
YoY Change	273.2%	-6382.43%	261.95%
Depreciation, Depletion And Amortization	$12.97K	$20.00K	$32.24K
YoY Change	-67.59%	-33.33%	-7.91%
Cash From Operating Activities	-$3.340M	-$1.490M	-$12.04M
YoY Change	145.59%	-18.58%	805.26%
INVESTING ACTIVITIES
Capital Expenditures	$39.58K	-$40.00K	-$150.0K
YoY Change	26288.0%	100.0%	1400.0%
Acquisitions
YoY Change
Other Investing Activities	$200.0K	$0.00	$0.00
YoY Change
Cash From Investing Activities	$140.0K	-$40.00K	-$150.0K
YoY Change		100.0%	1400.0%
FINANCING ACTIVITIES
Cash Dividend Paid	$200.3M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.050M	-690.0K	5.230M
YoY Change	15150.0%	-2400.0%	1587.1%
NET CHANGE
Cash From Operating Activities	-3.340M	-1.490M	-12.04M
Cash From Investing Activities	140.0K	-40.00K	-150.0K
Cash From Financing Activities	3.050M	-690.0K	5.230M
Net Change In Cash	-150.0K	-2.220M	-6.960M
YoY Change	-88.81%	21.98%	575.73%
FREE CASH FLOW
Cash From Operating Activities	-$3.340M	-$1.490M	-$12.04M
Capital Expenditures	$39.58K	-$40.00K	-$150.0K
Free Cash Flow	-$3.380M	-$1.450M	-$11.89M
YoY Change	148.47%	-19.89%	800.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53384	USD
CY2016Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2015Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2016Q4	us-gaap	Assets Assets	224739223	USD
CY2015Q4	us-gaap	Assets Assets	19862397	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	926529	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	521122	USD
CY2016Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2083472	USD
CY2015Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	1248708	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	109126	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	381950	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11588	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11250	USD
CY2016Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	1465272	USD
CY2015Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	16411	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	204837543	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2179441	USD
CY2016Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	USD
CY2015Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	108641	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	442589	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	433407	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	491791	USD
CY2016Q4	us-gaap	Liabilities Liabilities	205280132	USD
CY2015Q4	us-gaap	Liabilities Liabilities	3213280	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	6773	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	6438	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49323222	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153994922	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15569813	USD
CY2016Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	301824	USD
CY2015Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	511994	USD
CY2016Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	697321	USD
CY2015Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	963345	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	464797	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	181714	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	222269826	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	17226866	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120944	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	240366704	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29869852	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-223724025	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1052	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	19459091	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	16649117	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	224739223	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19862397	USD
CY2016	us-gaap	Contracts Revenue ContractsRevenue	5230196	USD
CY2015	us-gaap	Contracts Revenue ContractsRevenue	10640660	USD
CY2014	us-gaap	Contracts Revenue ContractsRevenue	10190205	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4836035	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5133512	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9319828	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11515071	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6222185	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10911724	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	2546159	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016	us-gaap	Depreciation Depreciation	143437	USD
CY2015	us-gaap	Depreciation Depreciation	141604	USD
CY2014	us-gaap	Depreciation Depreciation	149958	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	16494543	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	14043460	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	20381510	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-11264347	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-3402800	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-10191305	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2016	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11169376	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	168150	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-54581	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9893649	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2015	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	229192	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	45358	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-83021	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	7600	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	336	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10818	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-229192	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5394	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	7335712	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	613017	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	973132	USD
CY2016	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-889	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	18274145	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2240015	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3801720	USD
CY2014	pip	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	1107064	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	613017	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	193854173	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1655647	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2014	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	0	USD
CY2016	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-957070	USD
CY2015	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	299477	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	508817	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7847	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8137	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-762	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	216287896	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23841	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	297656	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	205023549	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3378959	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-9955395	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-3440705	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	193853121	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3211177	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9966213	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17686095	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1649994	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	455840	USD
CY2014	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	5653	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	401338	USD
CY2015	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	665914	USD
CY2014	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-1902094	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5202	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5367	USD
CY2015	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	481761	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1316457	USD
CY2014	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	0	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	129726	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8162372	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18643351	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10480979	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-54818	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2089493	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-341723	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3215981	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8474042	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86507	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92269	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7600	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-78907	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-84269	USD
CY2015	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-750007	USD
CY2014	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-999996	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1091740	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	683325	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	973132	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18141935	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	223125	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16733524	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1775	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-12841	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3073538	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-736776	USD
CY2015	us-gaap	Interest Paid InterestPaid	108391	USD
CY2014	us-gaap	Interest Paid InterestPaid	128073	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	2240015	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61822	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-15918	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	687	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-66877586	USD
CY2016	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	0	USD
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-6374	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	138425109	USD
CY2016	us-gaap	Interest Paid InterestPaid	0	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	405407	USD
CY2016	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-397383	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	789267	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	201508238	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30687	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	687	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3801720	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3800831	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-210170	USD
CY2016	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-266024	USD
CY2016	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	0	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	283514	USD
CY2015	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	36981	USD
CY2014	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	0	USD
CY2014Q3	pip	Initial Fund Value InitialFundValue	5200000	USD
CY2015Q1	us-gaap	Contracts Revenue ContractsRevenue	7068746	USD
CY2015Q2	us-gaap	Contracts Revenue ContractsRevenue	1149570	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	41054	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	93881	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2013	us-gaap	Maintenance Costs MaintenanceCosts	40000	USD
CY2015	us-gaap	Maintenance Costs MaintenanceCosts	100000	USD
CY2014Q3	pip	Additional Fund Value AdditionalFundValue	8800000	USD
CY2014Q3	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	28100000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	613017	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1655647	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2240015	USD
CY2015	pip	Share Based Compensation Extension Of Exercise Period ShareBasedCompensationExtensionOfExercisePeriod	75000	USD
CY2015	pip	Share Based Compensation Reversal From Stock Option Forfeitures ShareBasedCompensationReversalFromStockOptionForfeitures	129000	USD
CY2015	pip	Share Based Compensation Reversal Net ShareBasedCompensationReversalNet	53741	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	500000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3800000	USD
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36981	USD
CY2016Q4	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	0	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1992163	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1857256	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	895438	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	451805	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	987426	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	600390	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	159554	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	102632	USD
CY2015Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	81500000	USD
CY2015Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	113100000	USD
CY2015Q1	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	194600000	USD
CY2016	pip	Warrant Expiration Date WarrantExpirationDate	2015-01-28
CY2015Q4	pip	Beneficial Ownership Percentage Held By Affiliates BeneficialOwnershipPercentageHeldByAffiliates	0.0499	pure
CY2014Q2	pip	Common Stock Aggregate Amount Equity Offering CommonStockAggregateAmountEquityOffering	15000000	USD
CY2014	pip	Offering Costs In Connection With Controlled Equity Offering Sales Agreement OfferingCostsInConnectionWithControlledEquityOfferingSalesAgreement	100000	USD
CY2016	pip	Stock Sales Agent Commission Percentage StockSalesAgentCommissionPercentage	0.030	pure
CY2016Q4	pip	Equity Offering Remaining Aggregate Sales Available EquityOfferingRemainingAggregateSalesAvailable	3000000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	300000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	700000	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	400000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M12D
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.13
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.30
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.28
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2800000	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	800000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	900000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	USD
CY2016Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1051358	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1422781	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4495556	shares
CY2015Q3	us-gaap	Contracts Revenue ContractsRevenue	1155839	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-1226906	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	8044474	USD
CY2015Q4	us-gaap	Contracts Revenue ContractsRevenue	1266505	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1161084	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1964867	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-940469	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1658548	USD
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-1238400	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1324768	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2340932	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1463395	USD
CY2016Q1	us-gaap	Contracts Revenue ContractsRevenue	1005694	USD
CY2016Q2	us-gaap	Contracts Revenue ContractsRevenue	2111254	USD
CY2016Q3	us-gaap	Contracts Revenue ContractsRevenue	993885	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1254436	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-507744	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3989789	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2016Q4	us-gaap	Contracts Revenue ContractsRevenue	1119363	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	109235013	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	77801592	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5512378	USD
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Entity Registrant Name EntityRegistrantName	PHARMATHENE, INC
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	133900000	USD
CY2016	dei	Trading Symbol TradingSymbol	PIP
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68815195	shares
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	66810962	USD
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	66847586	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67726458	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67726458	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64382086	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64382086	shares
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.97
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.95
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65306962	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63986013	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57535325	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65657802	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63986013	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57535325	shares
CY2016	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	1052	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	217068969	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2016	pip	Amortization Of Premium And Discount On Short Term Investments AmortizationOfPremiumAndDiscountOnShortTermInvestments	-35572	USD
CY2015	pip	Amortization Of Premium And Discount On Short Term Investments AmortizationOfPremiumAndDiscountOnShortTermInvestments	0	USD
CY2014	pip	Amortization Of Premium And Discount On Short Term Investments AmortizationOfPremiumAndDiscountOnShortTermInvestments	0	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-53384	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-889	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	319021	USD
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our consolidated financial statements include significant estimates for share-based compensation, deferred tax assets, liabilities and valuation allowances, the expected economic life and value of our tangible assets and value of our indefinite lived intangible asset, and the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><i><font style="FONT-SIZE: 10pt"> Concentration of Credit Risk</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject us to concentrations of credit risk are primarily cash and cash equivalents, short-term investments, and billed and unbilled accounts receivable. We maintain our cash and cash equivalents in the form of U.S. Government money market accounts, U.S. Treasury Bills and U.S. government-sponsored enterprise debt. Because our billed and unbilled accounts receivable consist of amounts due from the U.S. Government, there is minimal credit risk.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	442589	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2090950	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2113107	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	380777	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1465272	USD
CY2016Q4	pip	Special One Time Cash Dividend Payable Per Share Common Stock SpecialOneTimeCashDividendPayablePerShareCommonStock	2.91
CY2016Q1	pip	Special One Time Cash Dividend Payable Per Share Common Stock SpecialOneTimeCashDividendPayablePerShareCommonStock	0
CY2016Q2	pip	Special One Time Cash Dividend Payable Per Share Common Stock SpecialOneTimeCashDividendPayablePerShareCommonStock	0
CY2016Q3	pip	Special One Time Cash Dividend Payable Per Share Common Stock SpecialOneTimeCashDividendPayablePerShareCommonStock	0
CY2016Q4	pip	Special One Time Cash Dividend Payable Per Share Common Stock SpecialOneTimeCashDividendPayablePerShareCommonStock	2.91
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3405069	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65635003	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64361842	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	149099	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	139883	USD
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	166205	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6849	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	8900	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3834	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1407280	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2352660	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3458334	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	817080	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	253655	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	434294	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6925123	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68608401	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68676033	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	442589	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	380777	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	319021	USD
CY2016Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	6482534	USD
CY2015Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	68227624	USD
CY2014Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	68357012	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6925123	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68608401	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68676033	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	442589	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	380777	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	319021	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.65	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.7	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.84	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0145	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0159	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0150	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0151	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0225	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0225	pure
CY2013Q1	pip	Common Stock Aggregate Amount Equity Offering CommonStockAggregateAmountEquityOffering	15000000	USD
CY2016	us-gaap	Fair Value Assumptions Weighted Average Volatility Rate FairValueAssumptionsWeightedAverageVolatilityRate	0.5	pure
CY2015Q4	pip	Additional Amount To Declare Stockholder As Acquiring Person Percentage AdditionalAmountToDeclareStockholderAsAcquiringPersonPercentage	0.005	pure
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	197083993	USD
CY2015Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3157563	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	197083993	USD
CY2016	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	3157563	USD
CY2015	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	0	USD
CY2014	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	0	USD
CY2016	pip	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Dilutive Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfDilutiveWarrants	0	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	193854173	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	805994	shares
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	70000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	385330	shares
CY2016Q4	pip	Operating Loss Carryforwards Amount Of Limitations On Use OperatingLossCarryforwardsAmountOfLimitationsOnUse	1000000	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	193854173	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2016	pip	Incremental Common Shares Attributable To Dilutive Effect Of Calloptions IncrementalCommonSharesAttributableToDilutiveEffectOfCalloptions	350840	shares
CY2016	pip	Incremental Common Shares Attributable To Dilutive Effect Of Warrants IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants	0	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6500000	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11900000	shares
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2016Q4	us-gaap	Government Contract Receivable Progess Payments Offset GovernmentContractReceivableProgessPaymentsOffset	800000	USD
CY2015Q4	us-gaap	Government Contract Receivable Progess Payments Offset GovernmentContractReceivableProgessPaymentsOffset	5800000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	400000	USD
CY2016Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	100000	USD
CY2016Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.91
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2016Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	153994922	USD
CY2016Q4	us-gaap	Available For Sale Securities Short Term Investments Amortized Cost AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost	66812014	USD
CY2016	pip	Cash And Cash Equivalents And Short Term Investments Amortized Cost CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost	220806936	USD
CY2016	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	-1052	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	220805884	USD
CY2014	us-gaap	Maintenance Costs MaintenanceCosts	100000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	71758245	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1148846	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3363841	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	10323810	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-124626	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-450656	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6211	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6909	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-6274	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4150	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	68482	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	7913	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	181958	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1049765	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	380689	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1429996	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1218	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	794807	USD
CY2016	pip	Lobbying Costs LobbyingCosts	198491	USD
CY2015	pip	Lobbying Costs LobbyingCosts	1047	USD
CY2014	pip	Lobbying Costs LobbyingCosts	57517	USD
CY2016	us-gaap	Income Tax Reconciliation Deductions Extraterritorial Income Exclusion IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion	6288553	USD
CY2015	us-gaap	Income Tax Reconciliation Deductions Extraterritorial Income Exclusion IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion	0	USD
CY2014	us-gaap	Income Tax Reconciliation Deductions Extraterritorial Income Exclusion IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion	0	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	817832	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	USD
CY2016	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2015	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	2949	USD
CY2014	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-308	USD
CY2016	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	73936484	USD
CY2015	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-143102	USD
CY2014	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-2580153	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-62767108	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	204848	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2641899	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1139746	USD
CY2015Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	218300	USD
CY2014Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	251524	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	8595085	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2512469	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	53240	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	53221	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	53221	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	8582	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	8525	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	8525	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2023-01-01
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	197100000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	490591	USD
CY2016	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	131822	USD
CY2016	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	249643	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	109126	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	153994922	USD
CY2016	pip	Cash And Cash Equivalents Unrealized Gain Loss CashAndCashEquivalentsUnrealizedGainLoss	0	USD
CY2016	pip	Short Term Investment Unrealized Gain Loss ShortTermInvestmentUnrealizedGainLoss	-1052	USD
CY2016	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2017-05-31
CY2016	pip	Operating Lease Term OperatingLeaseTerm	P10Y
CY2016	pip	Class Of Warrant Or Right Outstanding Warrants Expired ClassOfWarrantOrRightOutstandingWarrantsExpired	371423	shares
CY2015Q4	pip	Estimated Litigation Settlement Including Interest EstimatedLitigationSettlementIncludingInterest	205000000	USD
CY2015	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2014	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11107554	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD

Files In Submission

Name	View Source	Status
0001144204-17-014528-index-headers.html	Edgar Link	pending
0001144204-17-014528-index.html	Edgar Link	pending
0001144204-17-014528.txt	Edgar Link	pending
0001144204-17-014528-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pg29img1_10k.jpg	Edgar Link	pending
pip-20161231.xml	Edgar Link	completed
pip-20161231.xsd	Edgar Link	pending
pip-20161231_cal.xml	Edgar Link	unprocessable
pip-20161231_def.xml	Edgar Link	unprocessable
pip-20161231_lab.xml	Edgar Link	unprocessable
pip-20161231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v461002_10k.htm	Edgar Link	pending
v461002_ex23.htm	Edgar Link	pending
v461002_ex31-1.htm	Edgar Link	pending
v461002_ex31-2.htm	Edgar Link	pending
v461002_ex32-1.htm	Edgar Link	pending
v461002_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune Inc Stock $alt

2017 Q1 Form 10-K Financial Statement

#000114420417014528 Filed on March 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune Inc Stock $alt

2017 Q1 Form 10-K Financial Statement

#000114420417014528 Filed on March 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune Inc Stock $alt